PCM
MNTA

Prelude Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Prelude Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,700
Closed -$89K – 2296
2020
Q3 		$89K Buy
+1,700
New +$70.4K ﹤0.01% 949

Prelude Capital Management's MNTA Position: Q4 2020 in Review

Prelude Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 212,323 shares — an estimated $11.1M sold.

Prelude Capital Management first reported a position in MNTA in Q2 2013 and held it in 13 quarters. The position peaked at $11.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Prelude Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 212,323 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $11.1M.
  • Prelude Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • Prelude Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $11.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.